Development of antimicrobials for wound care: In-vitro and in-vivo assessments

Wounds

Volumn 16, Issue 11, 2004, Pages 344-347

  Davis, Stephen C ^a   Bouzari, Navid ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; GROWTH FACTOR;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM; BIOFILM; CONCENTRATION RESPONSE; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LABORATORY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; OUTPATIENT DEPARTMENT; PREDICTION; REVIEW; STAPHYLOCOCCUS AUREUS; WOUND CARE; WOUND INFECTION;

EID: 10444274149     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003 Jan;47(1):317-23.
2. Gelosia A, Baldassarri L, Deighton M, van Nguyen T. Phenotypic and genotypic markers of Staphylococcus epidermidis virulence. Clin Microbiol Infect 2001 Apr;7(4):193-9.
3. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Fourth Edition. Approved Standard. Villanova, PA: National Committee for Clinical Laboratory Standards, 1997. NCCLS Publication M7-A4.
4. Derendorf H. Pharmacokinetic evaluation of beta-lactam antibiotics. J Antimicrob Chemother 1989;24:407-13.
5. Mueller M, de la Peña A, Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: Kill curves versus MIC. Antimicrob Agents Chemother 2004;48(2):369-77.
6. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg 2003;29:631-5.
7. Caron E, Gold HS, Wennersten CB, et al. Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1997;41:2749-53.
8. Gunnison JB, Fraher MA, Jawetz E. Persistence of Staphylococcus aureus in penicillin in vitro. J Gen Microbiol 1963;34:335-49.
9. Pfaller MA, Sheehan DJ, Rex JH. Determination of fungicidal activities against yeasts and molds: Lessons learned from bactericidal testing and the need for standardization. Clinical Microbiology Reviews 2004;17(2):268-80.
10. Denny AE, Peterson LR, Gerding DN, et al. Serious staphylococcal infections with strains tolerant to bactericidal antibiotics. Arch Intern Med 1979;139:1026-31.
11. Bryan LE. Two forms of antimicrobial resistance: Bacterial persistence and positive function resistance. J Antimicrob Chemother 1989;23:817-23.
12. Kim KS, Anthony BF. Importance of bacterial growth phase in determining minimal bactericidal concentration of penicillin and methicillin. Antimicrob Agents Chemother 1981;19:1075-7.
13. Craig WA, Gudmundsson S. Postantibiotic effect. In: Lorian V (ed). Antibiotics in Laboratory Medicine. Baltimore, MD: Williams and Wilkins, 1996:296-329.
14. Andes D, Craig WA. Animal model pharmacokinetics and pharmacodynamics: A critical review. Int J Antimicrob Agents 2002;19:261-8.
15. Malaisrie SC, Malekzadeh S, Biedlingmaier JF. In vivo analysis of bacterial biofilm formation on facial plastic bioimplants. Laryngoscope 1998 Nov;108(11 Pt 1):1733-8.
16. Akiyama H, Kanzaki H, Tada J, Arata J. Staphylococcus aureus infection on cut wounds in the mouse skin: Experimental staphylococcal botryomycosis. J Dermatol Sci 1996 Mar;11(3):234-8.
17. Serralta VW, Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM. Lifestyles of bacteria in wounds: Presence of biofilms? WOUNDS 2001;13(1):29-34.
18. Mertz PM, Marshall DA, Eaglstein WH. Occlusive wound dressings to prevent bacterial invasion and wound infection. J Am Acad Dermatol 1985;12(4):662-8.
19. Oliveria MF, Davis SC, Mertz PM. Can occlusive dressing composition influence proliferation of bacterial wound pathogens? WOUNDS 1998;10(1):4-11.
20. Mertz PM, Oliverira-Gandia MV, Davis SC. The evaluation of a cadexomer iodine wound dressing on methicillin resistant Staphylococcus aureus (MRSA) in acute wounds. Dermatol Surg 1999;25:89-93.
21. Mertz PM, Davis SC, Cazzaniga AL, Drosou A, Eaglstein WH. Barrier and antimicrobial properties of 2-octyl cyanoacrylate derived wound treatment films. J Cutan Med Surg 2003;7(1):1-12.
22. Cazzaniga AL, Davis SC, Mertz PM. Effects of two topical antimicrobial agents on Staphylococcus aureus biofilms in a porcine model. JID 2003;121(1):1181 (Abstract).